Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts

$13.77

+0.10 (+0.73%)

(As of 07/26/2024 ET)

TAK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TAK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Takeda Pharmaceutical Analyst EPS Estimates

Current Year EPS Consensus Estimate:$1.29 EPS
Next Year EPS Consensus Estimate: $1.42 EPS

TAK Earnings Date and Information

Takeda Pharmaceutical has confirmed that its next quarterly earnings report will be published on Wednesday, July 31st, 2024.

Takeda Pharmaceutical Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
7/31/2024 (Confirmed)	-	-	-	-	-	-	-
2/1/2024	Q3 2024	-	$0.51	+$0.51	$0.79	-	$7.52 billion
10/26/2023	Q2 2024	-	$0.50	+$0.50	$0.86	-	$6.94 billion
7/27/2023	Q1 2024	-	$0.55	+$0.55	$0.89	-	$7.71 billion
5/11/2023	Q4 2023	-	$0.39	+$0.39	$0.70	-	$7.23 billion
2/2/2023	Q3 2023	-	$0.46	+$0.46	$0.63	-	$8.40 billion
10/27/2022	Q2 2023	-	$0.52	+$0.52	$0.90	-	$7.26 billion
Get the Latest News and Ratings for TAK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.
7/28/2022	Q1 2023	-	$0.56	+$0.56	$0.86	-	$7.51 billion
5/11/2022	Q4 2022	-	$0.38	+$0.38	$0.79	-	$7.19 billion
2/3/2022	Q3 2022	-	$0.54	+$0.54	$0.91	-	$8.21 billion
10/28/2021	Q2 2022	-	$0.45	+$0.45	$0.77	-	$7.67 billion
7/30/2021	Q1 2022	-	$0.51	+$0.51	$0.44	-	$8.68 billion
5/11/2021	Q4 2021	-	$0.41	+$0.41	$0.23	-	$7.27 billion
2/4/2021	Q3 2021	-	$0.56	+$0.56	$0.84	-	$8.01 billion
10/29/2020	Q2 2021	-	$0.47	+$0.47	$0.93	-	$7.43 billion
7/31/2020	Q1 2021	-	$0.57	+$0.57	$0.89	-	$7.46 billion
5/13/2020	Q4 2020	-	$0.13	+$0.13	$0.25	-	$7.09 billion
2/4/2020	Q3 2020	-	$0.53	+$0.53	$1.03	-	$7.90 billion
10/31/2019	Q2 2020	-	$0.59	+$0.59	$1.02	-	$7.56 billion
7/31/2019	Q1 2020	-	$0.56	+$0.56	$1.18	-	$7.73 billion

Takeda Pharmaceutical Earnings - Frequently Asked Questions

When is Takeda Pharmaceutical's earnings date?: Takeda Pharmaceutical has confirmed that its next quarterly earnings data will be published on Wednesday, July 31st, 2024. Learn more on TAK's earnings history.
What guidance has Takeda Pharmaceutical issued on next quarter's earnings?: Takeda Pharmaceutical issued an update on its FY 2024 earnings guidance on Thursday, May, 9th. The company provided EPS guidance of 2.900-2.900 for the period. The company issued revenue guidance of $29.3 billion-$29.3 billion, compared to the consensus revenue estimate of $26.5 million.
How much revenue does Takeda Pharmaceutical generate each year?: Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $28.20 billion.
How much profit does Takeda Pharmaceutical generate each year?: Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $994.06 million. TAK has generated $0.55 earnings per share over the last four quarters.
What is Takeda Pharmaceutical's price-to-earnings ratio?: Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 25.04 and a forward price-to-earnings ratio of 10.67. The price/earnings-to-growth ratio is 0.41.
What is Takeda Pharmaceutical's EPS forecast for next year?: Takeda Pharmaceutical's earnings are expected to grow from $1.29 per share to $1.42 per share in the next year, which is a 10.08% increase.